Global ETD Search

71	Clinical and Neurofunctional Substrates of Cognitive Behavioral Therapy on Secondary Social Anxiety Disorder in Primary Panic Disorder: A Longitudinal fMRI Study Seeger, Fabian, Yang, Yunbo, Straube, Benjamin, Kircher, Tilo, Höfler, Michael, Wittchen, Hans-Ulrich, Ströhle, Andreas, Wittmann, André, Gerlach, Alexander L., Pfleiderer, Bettina, Arolt, Volker, Hamm, Alfons, Lang, Thomas, Alpers, Georg W., Fydrich, Thomas, Lueken, Ulrike 05 August 2020 (has links) Clinicians frequently treat patients suffering from more than one mental disorder. As they have to choose which disorder to treat first, knowledge on generalization effects or even comorbidity-associated obstacles should guide the clinician’s decision. Patients with panic disorder (PD) and agoraphobia (AG) often suffer from other mental disorders, e.g. social anxiety disorder (SAD) [1]. Nevertheless, evidence is missing whether cognitive-behavioral therapy (CBT) for PD/AG generalizes to SAD or whether comorbid SAD impedes the treatment of primary PD/AG. info:eu-repo/classification/ddc/610 ddc:610
72	Social anxiety in adolescents and young adults from the general population: an epidemiological characterization of fear and avoidance in different social situations Ernst, Julia, Ollmann, Theresa Magdalena, König, Elisa, Pieper, Lars, Voss, Catharina, Hoyer, Jana, Rückert, Frank, Knappe, Susanne, Beesdo-Baum, Katja 11 June 2024 (has links) Social Anxiety Disorder (SAD) and, more generally, social fears are common in young people. Although avoidance behaviors are known to be an important maintaining factor of social anxiety, little is known about the severity and occurrence of avoidance behaviors in young people from the general population, hampering approaches for early identification and intervention. Symptoms, syndromes, and diagnoses of DSM-5 mental disorders including SAD were assessed in a random population-based sample of 14-21-year-olds (n = 1,180) from Dresden, Germany, in 2015/2016 using a standardized diagnostic interview (DIA-X-5/D-CIDI). An adapted version of the Liebowitz Social Anxiety Scale was used to ascertain the extent of social fears and avoidance. Diagnostic criteria for lifetime SAD were met by n = 82 participants, resulting in a weighted lifetime prevalence of 6.6%. Social anxiety was predominantly reported for test situations and when speaking or performing in front of others. Avoidance was most prevalent in the latter situations. On average, anxiety and avoidance first occurred at ages 11 and 12, respectively, with avoidance occurring in most cases either at about the same age as anxiety or slightly later. In the total sample, lifetime prevalence for most DSM-5 disorders increased with the severity of social anxiety and avoidance. Results underline the need for preventive or early intervention efforts especially regarding test anxiety and fear and avoidance of speaking in front of others. These situations are particularly relevant in youth. Avoidance behaviors may also be discussed as diagnostic marker for early case identification. info:eu-repo/classification/ddc/150 ddc:150
73	Does Virtual Reality Elicit Physiological Arousal In Social Anxiety Disorder Owens, Maryann 01 January 2013 (has links) The present study examined the ability of a Virtual Reality (VR) public speaking task to elicit physiological arousal in adults with SAD (n=25) and Controls (n=25). A behavioral assessment paradigm was employed to address three study objectives: (a) to determine whether the VR task can elicit significant increases in physiological response over baseline resting conditions (b) to determine if individuals with SAD have a greater increase from baseline levels of physiological and self-reported arousal during the in vivo speech task as opposed to the VR speech task and (c) to determine whether individuals with SAD experience greater changes in physiological and selfreported arousal during each speech task compared to controls. Results demonstrated that the VR task was able to elicit significant increases in heart rate, skin conductance, and respiratory sinus arrhythmia, but did not elicit as much physiological or self-reported arousal as the in vivo speech task. In addition, no differences were found between groups. Clinical implications of these findings are discussed Social anxiety disorder social anxiety adults in vivo sad anxiety virtual reality vr physiological arousal physiology public speaking social phobia phobia speech exposure therapy vret anxious heart rate hr skin conductance scl skin conductance response scr respiratory sinus arrhythmia rsa Clinical Psychology Psychology
74	Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology Baldwin, David S., Anderson, Ian M., Nutt, David J., Allgulander, Christer, Bandelow, Borwin, den Boer, Johan A., Christmas, David M., Davies, Simon, Fineberg, Naomi, Lidbetter, Nicky, Malizia, Andrea, McCrone, Paul, Nabarro, Daniel, O’Neill, Catherine, Scott, Jan, van der Wee, Nic, Wittchen, Hans-Ulrich 17 September 2019 (has links) This revision of the 2005 British Association for Psychopharmacology guidelines for the evidence-based pharmacological treatment of anxiety disorders provides an update on key steps in diagnosis and clinical management, including recognition, acute treatment, longer-term treatment, combination treatment, and further approaches for patients who have not responded to first-line interventions. A consensus meeting involving international experts in anxiety disorders reviewed the main subject areas and considered the strength of supporting evidence and its clinical implications. The guidelines are based on available evidence, were constructed after extensive feedback from participants, and are presented as recommendations to aid clinical decision-making in primary, secondary and tertiary medical care. They may also serve as a source of information for patients, their carers, and medicines management and formulary committees. info:eu-repo/classification/ddc/610 ddc:610

Page generated in 0.0809 seconds